Source: Fox News
Summary
GLP-1 medications, including semaglutide and tirzepatide, are increasingly used by young adults, particularly women, for weight loss and diabetes. A 2024 JAMA analysis found 162,439 young adults aged 18 to 25 received GLP-1 prescriptions in 2023. A 2025 Monitoring the Future survey reported 2% of students in grades 8, 10, and 12 used GLP-1s, with 2% using them without a prescription. A feature in The Cut described GLP-1 use as part of campus culture at some elite universities. Experts warn of potential risks, including muscle loss and long-term effects not yet studied in young, healthy individuals.
Our Reading
This guidance has been heard before.
GLP-1s are being used for weight loss in young adults, despite limited long-term data.
Young women are turning to these drugs to meet beauty standards and social pressures.
Experts caution against using them for cosmetic reasons rather than medical needs.
The same drugs that treat diabetes are now seen as a shortcut for appearance, not health.
Author: Evan Null
